UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Patient and companion shared decision making and satisfaction with decisions about starting cholinesterase medication at dementia diagnosis

McCabe, R; Pavlickova, H; Xanthopoulou, P; Bass, NJ; Livingston, G; Dooley, J; (2019) Patient and companion shared decision making and satisfaction with decisions about starting cholinesterase medication at dementia diagnosis. Age and Ageing , 48 (5) pp. 711-718. 10.1093/ageing/afz045. Green open access

[thumbnail of Bass_Patient and companion shared decision making and satisfaction with decisions about starting cholinesterase medication at dementia diagnosis_AAM.pdf]
Preview
Text
Bass_Patient and companion shared decision making and satisfaction with decisions about starting cholinesterase medication at dementia diagnosis_AAM.pdf - Accepted Version

Download (1MB) | Preview

Abstract

BACKGROUND: there is little research on how people with dementia are involved in treatment decisions at diagnosis. OBJECTIVE: to measure shared decision making when starting cholinesterase inhibitors, investigate associations with contextual factors and explore satisfaction and experience of the diagnostic meeting. SETTING: nine UK memory clinics in two geographical locations. SUBJECTS: 74 people receiving dementia diagnoses (with 69 companions) and 21 doctors. METHODS: we video-recorded 74 memory clinic consultations and rated doctor-shared decision making behaviours using the Observing Patient Involvement in Decision Making scale (OPTION-5 scale). Patients and companions rated their satisfaction and experience. Mixed-effects regressions investigated involvement and (i) number people present, meeting length, capacity, cognitive functioning, diagnosis; and (ii) patient/companion satisfaction and consultation experience. RESULTS: mean consultation time was 26.7 min. Mean OPTION-5 score was 22.5/100 (Standard Deviation = 17.3). Doctors involved patients in decisions more often when patients had mixed dementia (β = 10.13, 95% confidence interval 1.25-19.0, P = 0.025) and in shorter meetings (β = -0.51, 95% CI -0.87 to -0.15, P = 0.006). Patient and companion satisfaction were high and not associated with whether doctors invited patient involvement. Half of patients and one-third companions were uncertain about the meeting outcome, experienced communication barriers and negative emotions. CONCLUSIONS: consultations scored low on shared decision making, but were comparable to other settings and were not lower with more cognitively impaired patients. Negative patient and companion experiences reflect the importance of supporting healthcare providers to address patient and companion emotions and need for information.

Type: Article
Title: Patient and companion shared decision making and satisfaction with decisions about starting cholinesterase medication at dementia diagnosis
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/ageing/afz045
Publisher version: https://doi.org/10.1093/ageing/afz045
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Alzheimer’s disease, communication, dementia, older people, satisfaction, shared decision making
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry
URI: https://discovery.ucl.ac.uk/id/eprint/10074475
Downloads since deposit
57Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item